Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Thrombocytosis and ASXL1[original query]
Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
Haematologica 2011 Oct 96 (10): 1462-9.
Stein Brady L, Williams Donna M, O'Keefe Christine, Rogers Ophelia, Ingersoll Roxann G, Spivak Jerry L, Verma Amit, Maciejewski Jarek P, McDevitt Michael A, Moliterno Alison
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.
American journal of hematology 2016 Feb .
Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal
Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis.
American journal of clinical pathology 2017 May 147 (5): 444-452.
Song Jinming, Hussaini Mohammad, Zhang Hailing, Shao Haipeng, Qin Dahui, Zhang Xiaohui, Ma Zhenjun, Hussnain Naqvi Syeda Mahrukh, Zhang Ling, Moscinski Lynn
The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.
American journal of hematology 2017 Feb .
Mudireddy Mythri, Barraco Daniela, Hanson Curtis A, Pardanani Animesh, Gangat Naseema, Tefferi Ayal
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
Blood 2020 6 136 (16): 1851-1862.
Palomo Laura, Meggendorfer Manja, Hutter Stephan, Twardziok Sven, Ademà Vera, Fuhrmann Irene, Fuster-Tormo Francisco, Xicoy Blanca, Zamora Lurdes, Acha Pamela, Kerr Cassandra M, Kern Wolfgang, Maciejewski Jaroslaw P, Solé Francesc, Haferlach Claudia, Haferlach Torst
Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
Journal of clinical pathology 2020 3 73 (11): 728-736.
Liu Yen-Chun, Illar Gwendolyn M, Bailey Nathanael Gl
Thiol/Disulfide Balance in Older Patients with BCR-ABL Negative Myeloproliferative Neoplasms.
Clinical laboratory 2021 12 67 (12): .
Koyuncu Mahmut B, Cavusoglu Cagatay, Basir Hakan, Ilgan Mustafa, Ucar Mehmet A, Akdeniz Aydan, Tombak Anil, Tiftik Eyup N, Temel Gulhan O, Neselioglu Salim, Erel Ozc
[Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2022 6 43 (4): 323-329.
Tan Y X, Luo J, Huang J X, Luo D M, Liang H Y, Zhou X, Liu X L, Xu
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.
Blood cancer journal 2022 2 12 (2): 26.
Mangaonkar Abhishek A, Lasho Terra L, Ketterling Rhett P, Reichard Kaaren K, Gangat Naseema, Al-Kali Aref, Begna Kebede H, Pardanani Animesh, Al Ali Najla H, Talati Chetasi, Sallman David, Padron Eric, Patnaik Mrinal M, Tefferi Ayalew, Komrokji Ra
Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.
International journal of molecular sciences 2024 9 25 (18): .
Fei Fei, Amar Jariwala, Sheeja Pullarkat, Eric Loo, Yan Liu, Parastou Tizro, Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Andrew Artz, Feras Ally, Milhan Telatar, Ryotaro Nakamura, Guido Marcucci, Michelle Afkha
TOP